PortfolioScience on Tuesday announced today that INTL FCStone Inc. has selected its RiskAPI platform to analyze the exposure of its client portfolios. The RiskAPI platform will be included as part of INTL FCStone’s suite of risk management tools.
PortfolioScience is a provider of risk management skills. Its RiskAPI platform offers on-demand portfolio risk analysis. The service includes coverage of both listed and over the counter (OTC) derivatives.
INTL FCStone is a leading execution, clearing, risk, and market intelligence provider for commodities and other asset classes.
Commenting on the decision, Ittai Korin, PortfolioScience’s founder and President said in a statement: “as a global execution provider enabling clients to trade a diverse set of derivatives, INTL FCStone has a demanding set of risk management requirements.
“These include the need for sophisticated data, analytics, and computing, with which the firm can constantly monitor client and counter-party exposure.
Pure Markets' CEO Talks Business Model, 2020 OutlookGo to article >>
“We are pleased that the RiskAPI system was selected by the firm due to its ability to provide a high-performance, flexible and dynamic solution.”
David Wilusz, Director of Risk Valuations at INTL FCStone added: “PortfolioScience’s RiskAPI has demonstrated an ability to rapidly provide accurate risk analytics for complex portfolios.
“Market data is handled by them on the server-side and integration is light, which has meant relatively little time spent on setup, and more time managing risk. We are pleased to include PortfolioScience as part of our suite of risk management tools.”
INTL FCStone offers institutional clients access to blue chip international securities and American depositary receipts (ADRs). Earlier this year the company was ranked the top OTC market maker for the third consecutive year.
In 2017 alone, the company was attributed with a combined $29 billion in OTC trading. This accounted for 15 percent of all OTC value reported during the year.
Furthermore, the company’s total ADR value traded improved by 18 percent to reach $25 billion. This surpassed the increase incurred across the entire market which reached 12 percent.